MedPath

A Clinical Evaluation of a Unani Drug on Uterine Fibroid

Phase 2
Conditions
Health Condition 1: N80-N98- Noninflammatory disorders of female genital tract
Registration Number
CTRI/2022/08/044543
Lead Sponsor
Ayurvedic and Unani Tibbia College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Women in reproductive age group(20-45years) diagnosed with uterine fibroid upto 2-3cm.

Patient coming with pelvic pain, pelvic lump, menorrhagia with regular cycles.

Patient willing to sign the informed consent follow the protocol and participate in clinical trial voluntarily.

Exclusion Criteria

Patient unwilling to sign the consent form.

Patients who have abnormal finding such as hemorrhagic cyst, tubo-ovarian mass, suspected pregnancy, bicornuate uterus and septate uterus in ultrasonography will be excluded from the study.

Patient taking Hormonal therapy.

Patient having history of AIDS, Syphilis, and Gonorrhea.

History of Cardiovascular, Renal and Liver Disease.

History of Diabetes (Type 1 or Type 2)

History of Thyroid disease.

History of Bleeding disorder.

Patient having IUCD.

Patients with systemic disease and malignancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath